BioSpace News Archive

Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company, today announced the dosing of the first participant enrolled in the REPAIR-PD study with its lead nanocatalytic therapy, CNM-Au8, for the treatment of Parkinson’s disease (PD).

Theranica Bio-Electronics (Theranica), a bio-medical technology company developing advanced electroceuticals for migraine and other pain disorders, announced today that the journal of Expert Review of Medical Devices has published a device profile of its novel smartphone-controlled, prescription migraine wearable device, Nerivio™

Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative hematology solutions to drive better patient outcomes, announced the North American commercial availability for the next generation of its market leading SafeTrace Tx® Transfusion Management Software, a blood bank information system (BBIS).

Biocept, Inc. (NASDAQ: BIOC), announces that clinical data supporting the use of its Target Selector™ CTC platform as an aid in the monitoring and treatment of breast cancer will be presented in a poster session at the 2019 San Antonio Breast Cancer Symposium® (SABCS).

DNAnexus’ FedRAMP-authorized cloud-based platform exemplifies FDA strategy for enhancing the regulatory process through data, technology, and stakeholder engagement.